Finance

Lists
GLMD:NASDAQ
Galmed Pharmaceuticals Ltd
$3.82
-3.16%
(-0.12) 1D
$3.70
-3.27% (-0.12)
After hours
Closed: Sep 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GLMD...
Open
$3.81
High
$3.96
Low
$3.74
Mkt. cap
3.98M
Avg. vol.
39.76K
Volume
14.85K
52-wk high
$13.20
52-wk low
$3.29
EPS
-$16.55
Beta
0.66
Shares outstanding
1.04M
No. of employees
5
Open
$3.81
High
$3.96
Low
$3.74
Mkt. cap
3.98M
Avg. vol.
39.76K
Volume
14.85K
52-wk high
$13.20
52-wk low
$3.29
EPS
-$16.55
Beta
0.66
Shares outstanding
1.04M
No. of employees
5
News stories
From web sources and news partners
About Galmed Pharmaceuticals Ltd
CEO-
Employees5
Founded2000
Headquarters-
SectorBiotechnology
Websitegalmedpharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to GLMD in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GLMD in the last 3 months
Highest
Current $3.82
(-100.00%)
Average
(-100.00%)
Lowest
(-100.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Hold
Maintained
-
-
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.09M
2.10M
1.36M
1.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.01M
946.00K
684.00K
993.00K
Operating expense
2.10M
3.04M
2.04M
2.78M
Total operating expenses
2.10M
3.04M
2.04M
2.78M
Operating income
-2.10M
-3.04M
-2.04M
-2.78M
Other non operating income
-
-16.00K
-
-
EBT including unusual items
-1.89M
-4.82M
-1.91M
-2.72M
EBT excluding unusual items
-1.89M
-2.79M
-1.91M
-2.72M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.89M
-4.82M
-1.91M
-2.72M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
203.00K
420.00K
134.00K
154.00K
Interest expense
-
-79.00K
-
-102.00K
Net interest expenses
203.00K
341.00K
134.00K
52.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.07M
-3.02M
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps